Arrowhead Pharmaceuticals (NASDAQ:ARWR) Upgraded to “Buy” at Wall Street Zen
Arrowhead Pharmaceuticals (NASDAQ:ARWR – Get Free Report) was upgraded by investment analysts at Wall Street Zen from a “hold” rating to a “buy” rating in a report issued on Friday. A number of other equities research analysts have also issued reports on the company. Citigroup cut their target price on Arrowhead Pharmaceuticals from $21.00 to […]
Arrowhead Pharmaceuticals (NASDAQ:ARWR – Get Free Report) was upgraded by investment analysts at Wall Street Zen from a “hold” rating to a “buy” rating in a report issued on Friday. A number of other equities research analysts have also issued reports on the company. Citigroup cut their target price on Arrowhead Pharmaceuticals from $21.00 to […]
